This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

LIFEHOUSE: Description of the Tent Bucket -Immune Support

Sponsored by Metagenics, Inc.

About this trial

Last updated 3 years ago

Study ID

2020-002

Status

Active, not recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 69 Years
All
All

Trial Timing

Ended 2 years ago

What is this trial about?

This immune support program will be an extension to the existing LIFEHOUSE program. Essential employees in Gig Harbor, WA; Colonial Heights, VA; Lenexa, KS, and Santa Fe Springs, CA, will be offered complimentary supplementation with commercially available nutritional supplements supportive of immune health for several months. The outcome will be measured via blood parameters and questionnaire responses.

What are the participation requirements?

Yes

Inclusion Criteria

- Male or Female

- Ages 18-69, inclusive

- Metagenics' employees in Gig Harbor, WA; Colonial Heights, VA; Lenexa, KS, and Santa Fe Springs, CA

- General good health

- Willing to give written informed consent to participate in the study

No

Exclusion Criteria

- An allergy to any ingredient in Vit.D3 5000 and/or Immune Active

- A serious, unstable illness including cardiac, hepatic, renal, gastrointestinal, respiratory, endocrinologic, neurologic, psychiatric, immunologic/rheumatological, or oncological/hematologic disease.

- Hyperparathyroidism

- Granulomatous disorders including as sarcoidosis, tuberculosis, leprosy, berylliosis, histoplasmosis, and coccidioidomycosis

- Chronic renal insufficiency

- Nephrolithiasis

- Prior cancer diagnosis

- Known infection with human immunodeficiency virus (HIV), tuberculosis (TB), or Hepatitis B or C.

- Established psychiatric disease including moderate to severe depression, thought disorders and bipolar disorder

- Planned use of nutritional supplements (exclusive of multiple vitamin/mineral supplements and medical foods) containing in total more than 1,000 IU Vitamin D3 and/or 10 mg Zinc

- Use of pharmaceutical nitrates for any indication

- Use of drugs of abuse and recreational drugs/substances (such as but not limited to opioids, cocaine, phencyclidine (PCP), and methamphetamine)

- History of marijuana or cannabinoid abuse within 12 months prior to screening and for the duration of the study.

- History of alcohol abuse or a diagnosis of alcoholism within 12 months prior to screening and for the duration of the study.

- Pregnant or breastfeeding women

- Inability to comply with study and/or follow-up visits.

- Any concurrent condition (including clinically significant abnormalities in medical history, physical examination or laboratory evaluations) which, in the opinion of the Principal Investigator (PI), would preclude safe participation in this study or interfere with compliance.

- Any sound medical, psychiatric, and/or social reason which, in the opinion of the PI, would preclude safe participation in this study or interfere with compliance.

Locations

Location

Status